Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UFUR Plus Thalidomide in Advanced HCC
NCT00519688Phase 2Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Jul 2006
- Primary completion
- Aug 2010
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur, thalidomide in hepatocellular carcinoma (HCC), sponsored by National Taiwan University Hospital. Started Jul 2006; status: completed.
02
Drugs
tegafurthalidomide
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00519688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00519688.